Plasma cholecystokinin and gallbladder responses to intraduodenal fat in gallstone patients.
Impaired gallbladder emptying is one of the various factors suggested to be involved in the pathogenesis of gallstones. The present study was undertaken to determine whether gallbladder emptying, endogenous cholecystokinin (CCK) secretion, or their interrelation is altered in patients with gallstones. After intraduodenal administration of 60 ml corn oil, plasma CCK concentration was measured by a sensitive and specific radioimmunoassay and gallbladder emptying by cholescintigraphy. Patients with gallstones (N = 20) produced significantly less endogenous CCK (105 +/- 17 pmol/liter 60 min; P less than 0.001) than control subjects (191 +/- 11 pmol/liter 60 min, N = 20); gallbladder emptying in the patients was significantly decreased at 5, 10, 40, 45, and 50 min but the reduction in gallbladder emptying did not reach statistical significance at 60 min (patients 44 +/- 8%, control subjects 60 +/- 4%). In addition, the gallbladder responsiveness to intravenous infusion of the synthetic CCK analog cerulein was investigated. Based on the results of gallbladder emptying in response to endogenous and exogenous CCK, four subgroups of gallstone patients were identified: (1) a group (N = 7) with normal gallbladder sensitivity to CCK, (2) a group (N = 6) with significantly increased gallbladder sensitivity to CCK, (3) a group (N = 6) with impaired gallbladder emptying after corn oil due to a significantly reduced endogenous CCK secretion but with normal gallbladder sensitivity to CCK, and (4) one patient whose gallbladder was unresponsive to CCK and was found to have chronic cholecystitis at surgery.
Masclee
A A
AA
Department of Medicine, St. Radboud Hospital, University of Nijmegen, The Netherlands.
Jansen
J B
JB
Driessen
W M
WM
Geuskens
L M
LM
Lamers
C B
CB
D002108:Ceruletide / Q000494:pharmacology; D002766:Cholecystokinin / Q000031:analogs & derivatives / Q000097:blood* / Q000502:physiology; D002769:Cholelithiasis / Q000097:blood / Q000503:physiopathology*; D003314:Corn Oil / Q000008:administration & dosage*; D004386:Duodenum / Q000503:physiopathology*; D005260:Female; D005704:Gallbladder / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010938:Plant Oils / Q000008:administration & dosage*
D010938:Plant Oils; D003314:Corn Oil; D002108:Ceruletide; D002766:Cholecystokinin